Proteomics

Dataset Information

0

Validation and application of a novel KLK6 activity based probe (IMP2352)


ABSTRACT: Pancreatic cancer has the lowest survival rate of all common cancers due to late diagnosis and limited treatment options. Serine hydrolases are known to mediate cancer progression and metastasis through initiation of signaling cascades and cleavage of extracellular matrix proteins, and the kallikrein-related peptidase (KLK) family of secreted serine proteases have emerging roles in pancreatic ductal adenocarcinoma (PDAC). However, the lack of reliable activity-based probes (ABP) to profile KLK activity has hindered progress in validation of these enzymes as potential targets or biomarkers. Here, we developed potent and selective ABPs for KLK6 by using a positional scanning combinatorial substrate library and characterized their binding mode and interactions by X-ray crystallography. The optimized KLK6 probe IMP-2352 (kobs/I = 11,000 M-1 s-1) enabled selective detection of KLK6 activity in a variety of PDAC cell lines, and we observed that KLK6 inhibition reduced the invasiveness of PDAC cells that secrete active KLK6. KLK6 inhibitors were combined with N-terminomics to identify potential secreted protein substrates of KLK6 in PDAC cells, providing insights into KLK6-mediated invasion pathways. These novel KLK6 ABPs offer a new toolset to validate KLK6 and associated signaling partners as targets or biomarkers across a range of diseases.

INSTRUMENT(S): Q Exactive

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Cell Culture

SUBMITTER: Leran Zhang  

LAB HEAD: Edward W Tate

PROVIDER: PXD035111 | Pride | 2023-03-10

REPOSITORIES: Pride

altmetric image

Publications

A KLK6 Activity-Based Probe Reveals a Role for KLK6 Activity in Pancreatic Cancer Cell Invasion.

Zhang Leran L   Lovell Scott S   De Vita Elena E   Jagtap Pravin Kumar Ankush PKA   Lucy Daniel D   Goya Grocin Andrea A   Kjær Svend S   Borg Annabel A   Hennig Janosch J   Miller Aubry K AK   Tate Edward W EW  

Journal of the American Chemical Society 20221122 49


Pancreatic cancer has the lowest survival rate of all common cancers due to late diagnosis and limited treatment options. Serine hydrolases are known to mediate cancer progression and metastasis through initiation of signaling cascades and cleavage of extracellular matrix proteins, and the kallikrein-related peptidase (KLK) family of secreted serine proteases have emerging roles in pancreatic ductal adenocarcinoma (PDAC). However, the lack of reliable activity-based probes (ABPs) to profile KLK  ...[more]

Similar Datasets

2016-03-12 | E-GEOD-79147 | biostudies-arrayexpress
2024-04-23 | PXD043111 | Pride
2010-06-30 | E-GEOD-2058 | biostudies-arrayexpress
2017-07-20 | PXD005139 | Pride
2010-12-31 | E-GEOD-22028 | biostudies-arrayexpress
2021-05-13 | PXD024405 | Pride
2014-01-16 | E-GEOD-43555 | biostudies-arrayexpress
2014-12-16 | PXD001122 | Pride
2023-06-21 | PXD040359 | Pride
2022-08-12 | PXD029832 | Pride